ATE169499T1 - Topische antiglaukoma zusammensetzungen, enthaltend karbonhydrasehemmer und beta-blocker - Google Patents

Topische antiglaukoma zusammensetzungen, enthaltend karbonhydrasehemmer und beta-blocker

Info

Publication number
ATE169499T1
ATE169499T1 AT93906084T AT93906084T ATE169499T1 AT E169499 T1 ATE169499 T1 AT E169499T1 AT 93906084 T AT93906084 T AT 93906084T AT 93906084 T AT93906084 T AT 93906084T AT E169499 T1 ATE169499 T1 AT E169499T1
Authority
AT
Austria
Prior art keywords
hydrase
inhibitors
compositions containing
containing carbon
compositions
Prior art date
Application number
AT93906084T
Other languages
English (en)
Inventor
Thomas Robert Dean
Louis Desantis Jr
Original Assignee
Alcon Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Lab Inc filed Critical Alcon Lab Inc
Application granted granted Critical
Publication of ATE169499T1 publication Critical patent/ATE169499T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
AT93906084T 1992-02-21 1993-02-19 Topische antiglaukoma zusammensetzungen, enthaltend karbonhydrasehemmer und beta-blocker ATE169499T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83986992A 1992-02-21 1992-02-21

Publications (1)

Publication Number Publication Date
ATE169499T1 true ATE169499T1 (de) 1998-08-15

Family

ID=25280847

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93906084T ATE169499T1 (de) 1992-02-21 1993-02-19 Topische antiglaukoma zusammensetzungen, enthaltend karbonhydrasehemmer und beta-blocker

Country Status (10)

Country Link
EP (1) EP0625903B1 (de)
JP (2) JP2965267B2 (de)
AT (1) ATE169499T1 (de)
AU (1) AU677577B2 (de)
CA (1) CA2129037C (de)
DE (1) DE69320329T2 (de)
DK (1) DK0625903T3 (de)
ES (1) ES2118941T3 (de)
HK (1) HK1009941A1 (de)
WO (1) WO1993016701A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG84487A1 (en) 1991-04-17 2001-11-20 Merck & Co Inc Ophthalmic compositions comprising combinations of a carbonic anhydrase inhibitor and a b-adrenergic antagonist
US6316443B1 (en) 1994-08-04 2001-11-13 Merck & Co., Inc. Ophthalmic compositions comprising combinations of a carbonic anhydrase inhibitor and a β-adrenergic antagonist
US6071904A (en) * 1996-12-11 2000-06-06 Alcon Laboratories, Inc. Process for manufacturing ophthalmic suspensions
WO1999000133A1 (en) * 1997-06-26 1999-01-07 Merck & Co., Inc. Method for optimizing retinal and optic nerve health
WO1999037292A2 (en) * 1998-01-23 1999-07-29 Merck Sharp & Dohme B.V. Carbonic anhydrase inhibitor for increasing oxygen tension in the optic nerve and retina
WO2000007584A2 (en) * 1998-08-04 2000-02-17 Wisconsin Alumni Research Foundation Method of reducing retinal ganglion cell degeneration
JP4000505B2 (ja) * 1999-12-01 2007-10-31 第一三共株式会社 緑内障を治療するための併用剤
WO2004045644A1 (ja) * 2002-11-18 2004-06-03 Santen Pharmaceutical Co., Ltd. Rhoキナーゼ阻害剤とβ遮断薬からなる緑内障治療剤
US9649300B2 (en) * 2013-08-28 2017-05-16 University of Pittsburgh—of the Commonwealth System of Higher Education Inhibition of WNT, TGF beta and Hippo signaling pathways to treat cancer, organ fibrosis and metabolic disorders
EP3559005A1 (de) 2016-12-21 2019-10-30 Biotheryx Inc. Thienopyrrolderivate zur verwendung beim targeting von proteinen, zusammensetzungen, verfahren und verwendungen davon

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3655663A (en) * 1969-04-21 1972-04-11 Burton K Wasson 4-(3-secondary amino-2-hydroxy-proxy) 1 2 5-thiadiazoles
US4911920A (en) * 1986-07-30 1990-03-27 Alcon Laboratories, Inc. Sustained release, comfort formulation for glaucoma therapy
US4863922A (en) * 1984-12-12 1989-09-05 Merck & Co., Inc. Substituted aromatic sulfonamides as antiglaucoma agents, compositions and use
ATE41002T1 (de) * 1984-12-12 1989-03-15 Merck & Co Inc Substituierte aromatische sulfonamide, ihre herstellung und diese enthaltende ophthalmische zubereitungen.
US4797413A (en) * 1986-05-14 1989-01-10 Merck & Co., Inc. Thieno thiopyran sulfonamide derivatives, pharmaceutical compositions and use
US4731368A (en) * 1986-12-08 1988-03-15 Merck & Co., Inc. Thienopyridine sulfonamides and their ophthalmological formulation
US4751231A (en) * 1987-09-16 1988-06-14 Merck & Co., Inc. Substituted thieno[2,3-b]pyrrole-5-sulfonamides as antiglaucoma agents
EP0309028A3 (de) * 1987-09-16 1990-06-27 Merck & Co. Inc. Substituierte Thieno[2,3-b]furan-2-sulfonamide als Antiglaukommittel
US4946859A (en) * 1989-07-31 1990-08-07 Merck & Co., Inc. 4-(2-methyl-2-hydroxypropylamino)-5,6-dihydrothieno-[2,3-b]thiopyran-2-sulfonamide-7,7-dioxide
US5153192A (en) * 1990-04-09 1992-10-06 Alcon Laboratories, Inc. Thiophene sulfonamides useful as carbonic anhydrase inhibitors
IE911192A1 (en) * 1990-04-12 1991-10-23 Merck & Co Inc Substituted aromatic sulfonamides as antiglaucoma agents
ATE141502T1 (de) * 1991-01-15 1996-09-15 Alcon Lab Inc Verwendung von karrageenan in topischen ophthalmologischen zusammensetzungen
CA2064160C (en) * 1991-03-27 1998-08-11 Paul J. T. Missel Use of combinations of gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions
WO1992018124A1 (en) * 1991-04-17 1992-10-29 Merck & Co., Inc. OPHTHALMIC COMPOSITIONS COMPRISING COMBINATIONS OF A CARBONIC ANHYDRASE INHIBITOR AND A β-ADRENERGIC ANTAGONIST

Also Published As

Publication number Publication date
DE69320329D1 (de) 1998-09-17
DK0625903T3 (da) 1999-05-10
JP2965267B2 (ja) 1999-10-18
WO1993016701A3 (en) 1994-01-06
EP0625903B1 (de) 1998-08-12
WO1993016701A2 (en) 1993-09-02
AU3725793A (en) 1993-09-13
HK1009941A1 (en) 1999-06-11
EP0625903A1 (de) 1994-11-30
AU677577B2 (en) 1997-05-01
CA2129037A1 (en) 1993-09-02
DE69320329T2 (de) 1998-12-24
CA2129037C (en) 1998-03-24
JPH10324640A (ja) 1998-12-08
ES2118941T3 (es) 1998-10-01
JPH07504899A (ja) 1995-06-01

Similar Documents

Publication Publication Date Title
AU1387088A (en) Use of a prostaglandin in combination with an adrenergic blocking agent for reduction of intraocularpressure
PT639563E (pt) Utilizacao de ester de isopropilo de fluprostenol para a producao de um medicamento para o tratamento do glaucoma e hipertensao ocular
CA2080223A1 (en) Thiophene sulfonamides useful as carbonic anhydrase inhibitors
ATE169499T1 (de) Topische antiglaukoma zusammensetzungen, enthaltend karbonhydrasehemmer und beta-blocker
IE811654L (en) Ophthalmic composition
ATE223200T1 (de) Einen carboanhydrase-hemmer und xanthangummi enthaltendes augenarzneimittel
PT87620A (pt) Process for preparing thiophene sulfonamide antiglaucoma agents
ES2095975T3 (es) Uso de combinaciones de polisacaridos gelificantes y substratos portadores de medicamento, finamente divididos, para composiciones oftalmicas de uso topico.
DE3167999D1 (en) Ophthalmic compositions of carbonic anhydrase inhibitors for topical application in the treatment of elevated intraocular pressure
WO1992000287A3 (en) Analogs of carbonic anhydrase inhibitors and their use as topical iop inhibitors
KR880001290A (ko) β-차단제 및 필로카르핀-함유 제제
JPS6450886A (en) Substituted thieno(2,3-b)thiophene-2-sulfonamides as antiglaucoma
ATE49113T1 (de) Augentropfenspiegel.
ID22073A (id) Turunan-turunan nitrometil tiobenzena sebagai bahan penghambat aldosa reduktase
EP0527748A4 (en) Use of prostaglandin f 3 alpha as an ocular hypotensive agent

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee